A1 and A2 Bovine Milk, the Risk of Beta-casomorphin-7 and Its Possible Effects on Human Health: (II) Possible Effects of Beta-casomorphin-7 on Human Health
Abstract
Beta-casomorphine-7 (BCM-7), which is an opioid peptide during digestion of A1 milk, has been claimed as a possible cause of some health problems. There are some studies about the role of β- casomorphine-7 in some diseases such as type 1 diabetes, cardiovascular diseases, autism, schizophrenia, sudden infant death syndrome, apnea, constipation. For example, β- casomorphine-7 destroys pancreatic β cells, leading to the emergence of type 1 diabetes. It affects T and B cells related to immunity and negatively affects the autoimmune system.
The aim of this study is to reveal the diseases that can caused by β- casomorphine-7 in terms of both animal and human health, in this way to contribute to the reduction of the costs of animal and human health and to create an awareness.Keywords
Full Text:
PDFReferences
Boro P, Naha BC, Saikia DP & Prakash, C (2016) A1 and A2 milk & its impact on human health. International Journal of Science and Nature 7(1): 01-05.
Bell SJ, Grochoski, GT & Clarke AJ (2006). Health implications of milk containing β-casein with the A2 genetic variant. Critical Reviews in Food Science and Nutrition 46(1): 93-100.
Brantl V, Teschemacher H, Henschen A & Lottspeich F (1979). Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bo-vine casein peptone, Hoppe-Seyler s Zeitschrift für Physiologische Chemie 360(2): 1211-1224.
Brooks JG (1982). Apnea of infancy and sudden in-fant death syndrome, American Journal of Dis-eases of Children 136(11): 1012-1023.
Cade R, Wagemaker H, Privette R, Fregly M, Rogers J & Orlando J (1990) The effect of dialysis and diet on schizophrenia, Psychiatry: A World Per-spective 3(900): 494-500.
Cade R, Privette M, Fregly M, Rowland N, Sun Z, Zele V, Wagemaker H & Edelstein C (2000). Autism and schizophrenia: intestinal disorders. Nutri-tional Neuroscience 3(1): 57-72.
Elliott R, Harris D, Hill J, Bibby N & Wasmuth H, (1999). Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consump-tion. Diabetologia 42(3): 292-296.
Hartwig A, Gauly M, Erhardt G, Teschemacher H & Lehmann W (1997) Influence of genetic poly-morphisms in bovine milk on the occurrence of bioactiand peptides [beta-caso-morphins], Milk protein polymorphism, Palmerston North (New Zealand), Feb 1997.
Hedner J & Hedner T (1987). β-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. Life Sciences 41(20): 2303-2312.
Ho S, Woodford K, Kukuljan S & Pal S (2014). Com-parative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study. European Journal of Clinical Nutrition 68(9): 994.
Jaiswal KP, De S & Sarsavan A (2014). Review on bovine beta-casein (A1, A2) gene polymor-phism and their potentially hazardous on hu-man health. International Journal of Environ-ment & Animal Conservation 03 (01).
Jinsmaa Y & Yoshikawa M (1999b). Enzymatic re-lease of neocasomorphin and β-casomorphin from bovine β-casein. Peptides 20(8), 957-962.
Kamiński S, Cieślińska A & Kostyra E (2007). Poly-morphism of bovine beta-casein and its poten-tial effect on human health. Journal of Applied Genetics 48(3): 189-198.
Knivsberg A, Reichelt K, Høien T & Nødland M, (2002). A randomised, controlled study of die-tary intervention in autistic syndromes. Nutri-tional Neuroscience 5(4): 251-261.
Kost NV, Sokolov ОY, Kurasova ОB, Dmitriev AD, Tarakanova JN, Gabaeva МV, Zolotarev YA, Dadayan АK, Grachev SA & Korneeva ЕV (2009). β-Casomorphins-7 in infants on differ-ent type of feeding and different levels of psy-chomotor development. Peptides 30(10): 1854-1860.
Laugesen M & Elliott R (2003). Ischaemic heart dis-ease, Type 1 diabetes, and cow milk A1 β-casein. The New Zealand Medıcal Journal 116(1168): 1-19.
Lindström L, Nyberg F, Terenius L, Bauer K, Besev G, Gunne L, Lyrenäs S, Willdeck-Lund G & Lind-berg B (1984). CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis. The American Journal of Psychiatry 141(9): 1059-1066.
McLachlan C (2001). β-casein A1, ischaemic heart disease mortality, and other illnesses. Medical Hypotheses 56 (2): 262-272.
Mishra B, Mukesh M, Prakash B, Sodhi M, Kapila R, Kishore A, Kataria R, Joshi B, Bhasin V & Ra-sool T (2009). Status of milk protein, b-casein variants among Indian milch animals. Indian J Anim Sci 79: 722-725.
Ng-Kwai-Hang K & Grosclaude F (2003). Genetic pol-ymorphism of milk proteins, In: Advanced Dairy Chemistry—1 Proteins, Eds: Springer, 739-816.
NIH (2010). Consensus Development Conference: Lactose Intolerance and Health February, 22–24.
Priyadarshini P, Mishra C, Mishra B, Swain K, Rout M & Mishra SP (2018). Impact of milk protein on human health: A1 verses A2, IJCS, 6 (1): 531-535.
Reichelt K, Ekrem J & Scott H (1990) Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition 42 (1): 1-11.
Reichelt KL, Knivsberg A-M, Lind G & Nødland, M., (1991). Probable etiology and possible treat-ment of childhood autism. Brain Dysfunction.
Sodhi M, Mukesh M, Mishra B, Kishore A, Prakash B, Kapil R, Khate K, Kataria R & Joshi B (2012). Screening of taurine and crossbred breeding bulls for A1/A2 variants of β-casein gene. The Indian Journal of Animal Sciences 82(1): 2-9.
Sun Z, Cade JR, Fregly MJ & Privette RM (1999). β-Casomorphin induces Fos-like immunoreactivi-ty in discrete brain regions relevant to schizo-phrenia and autism. Autism 3(1): 67-83.
Sun Z, Cade RJ (1999). A peptide found in schizo-phrenia and autism causes behavioural changes in rats. Autism 3(1): 85-95.
Sun, Z., Zhang, Z., Wang, X., Cade, R., Elmir, Z. and Fregly, M., 2003, Relation of β-casomorphin to apnea in sudden infant death syndrome, Pep-tides, 24 (6): 937-943.
Swinburn B (2004). Beta casein A1 and A2 in milk and human health. Report to New Zealand Food Safety Authority, 1-43
Tailford KA, Berry CL, Thomas AC & Campbell JH, (2003). A casein variant in cow's milk is athero-genic. Atherosclerosis 170(1): 13-19.
Wasilewska J, Sienkiewicz-Szłapka E, Kuźbida E, Jar-mołowska B, Kaczmarski M & Kostyra E (2011). The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE). Neuropeptides 45(3): 189-195.
Whiteley P, Haracopos D, Knivsberg A-M, Reichelt KL, Parlar S, Jacobsen J, Seim A, Pedersen L, Schondel M & Shattock P (2010). The ScanBrit randomised, controlled, single-blind study of a gluten-and casein-free dietary intervention for children with autism spectrum disorders. Nutri-tional Neuroscience 13(2): 87-100.
Woodford K (2011). Milk Proteins and Human Health: A1 Versus A2 Beta-Casein, GPCE, Sydney, 1-6.
Woodford KB (2007). A2 milk, farmer decisions, and risk management, Proceedings of the 16th In-ternational Farm Management Congress: Peer reviewed papers, 641-648
DOI: https://doi.org/10.15316/SJAFS.2018.147
Refbacks
- There are currently no refbacks.
Bu eser Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.